相关实验视频

Updated: Jul 12, 2025

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

设计了一种双向的HA-TPP/A纳米粒子,用于针对胃肠道癌症中KRAS-TP53共突变的组合疗法

Yong Mei¹, Xiaohua Qin², Zhenyu Yang²

¹Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510080, China.

Bioactive materials

|October 25, 2023

概括

一种新的纳米粒子疗法在胃肠道癌症中准了KRAS和突变p53 (mutp53). 这种方法降解了mutp53并产生AMG510,显示出治疗侵略性瘤的前景.

科学领域:

在瘤学瘤学.
纳米医学是一种纳米医学.
分子生物学分子生物学

背景情况:

KRAS-TP53共同突变与胃肠道癌症的预后不佳有关.
针对KRAS和TP53突变提供了一个新的治疗策略.

研究的目的:

开发和评估一种新型纳米粒子 (HA-TPP/A),用于在胃肠道癌症中共同准KRAS和突变p53 (mutp53).
评估HA-TPP/A在抑制瘤信号和减少瘤进展方面的疗效.

主要方法:

合成了用 Hyaluronic 酸-TPP 合物功能化的自组装纳米粒子 (HA-TPP/A).
纳米颗粒共释放AMG510并通过依赖于ubiquitination的蛋白质体通路诱导mutp53降解.
在体外和体内研究评估了KRAS-TP53共突变模型中的治疗疗效.

主要成果:

HA-TPP/A纳米颗粒诱导了mutp53的降解,并取消了其功能获取表型.
这些纳米粒子增强了对AMG510的敏感性,减少了癌细胞的增殖和迁移.
在携带瘤的小鼠模型中观察到显著的治疗疗效,其表现优于单剂治疗.

结论:

HA-TPP/A代表了第一个能够共同准KRAS和TP53突变的纳米粒子.
这种新的方法显示出治疗高度恶性胃肠道瘤的前景,使用KRAS-TP53协同改变.
这些发现可能会扩大AMG510在胃肠道瘤学的临床应用.

关键词:

共同突变是一种共同突变.双重准可以实现.胃肠道癌症是什么意思在HA-TPP/A纳米粒子中.克拉斯 (Kras) 是一个国家.线粒体向向的目标这就是TP53的特点.

更多相关视频

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...